Yale University
Debiopharm and Yale University to develop autoimmune treatment
May 5, 2011Research and Development Debiopharm, Yale University
Debiopharm is teaming up with researchers at Yale University to develop Debio 1036, a first-in-class inhibitor for autoimmune and inflammatory …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
